Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: Possible roles in motor neuron survival

Neuroscience

Volumn 143, Issue 2, 2006, Pages 419-430

  Wootz, H ^a   Weber, E ^b   Korhonen, L ^a,c   Lindholm, D ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

Author keywords

ALS; cathepsinD; cystatinB; cystatinC; microglia; nerve cell death

Indexed keywords

ASPARTIC PROTEINASE; CASPASE; CATHEPSIN D; COPPER ZINC SUPEROXIDE DISMUTASE; CYSTATIN B; CYSTATIN C; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEINASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL SURVIVAL; CONTROLLED STUDY; GENE OVEREXPRESSION; LYSOSOME; MICROGLIA; MOTONEURON; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BLOTTING, WESTERN; CATHEPSIN D; CYSTATINS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MOTOR NEURONS; NEUROGLIA; PHOSPHOPYRUVATE HYDRATASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 33751233260     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.07.048     Document Type: Article

References (46)

1. Benchoua A., Braudeau J., Reis A., Couriaud C., and Onteniente B. Activation of proinflammatory caspases by cathepsin B in focal cerebral ischemia. J Cereb Blood Flow Metab 24 (2004) 1272-1279
2. Brännvall K., Hjelm H., Korhonen L., Lahtinen U., Lehesjoki A.E., and Lindholm D. Cystatin-B is expressed by neural stem cells and by differentiated neurons and astrocytes. Biochem Biophys Res Commun 308 (2003) 369-374
3. Bruijn L., Miller T.M., and Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27 (2004) 723-749
4. Cataldo A.M., Barnett J.L., Pieroni C., and Nixon R.A. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J Neurosci 17 (1997) 6142-6151
5. Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillee S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., Brown Jr. R.H., Julien J.P., Goldstein L.S., and Cleveland D.W. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302 (2003) 113-117
6. Ekdahl C., Mohapel P., Weber E., Bahr B., Blomgren K., and Lindvall O. Caspase-mediated cell death of newly formed neurons in the adult rat dentate gyrus following status epilepticus. Eur J Neurosci 16 (2002) 1463-1471
7. Ekegren T., Grundstrom E., Lindholm D., and Aquilonius S.M. Upregulation of Bax protein and increased DNA degradation in ALS spinal cord motor neurons. Acta Neurol Scand 100 (1999) 317-321
8. Felbor U., Kessler B., Mothes W., Goebel H.H., Ploegh H.L., Bronson R.T., and Olsen B.R. Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci U S A 99 (2002) 7883-7888
9. Fiebiger E., Meraner P., Weber E., Fang I.-F., Ploegh H., Stingl G., and Maurer D. Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J Exp Med 193 (2001) 881-892
10. Foghsgaard L., Wissing D., Mauch D., Lademann U., Bastholm L., Boes M., Elling F., Leist M., and Jaattela M. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 153 (2001) 999-1010
11. Foghsgaard L., Lademann U., Wissing D., Poulsen B., and Jaattela M. Cathepsin B mediates tumor necrosis factor-induced arachidonic acid release in tumor cells. J Biol Chem 277 (2002) 39499-39506
12. Guegan C., Vila M., Rosoklija G., Hays A.P., and Przedborski S. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J Neurosci 21 (2001) 6569-6576
13. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
14. Inoue H., Tsukita K., Iwasato T., Suzuki Y., Tomioka M., Tateno M., Nagao M., Kawata A., Saido T.C., Miura M., Misawa H., Itohara S., and Takahashi R. The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model. EMBO J 22 (2003) 6665-6674
15. Johansson A.C., Steen H., Ollinger K., and Roberg K. Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Death Differ 10 (2003) 1253-1259
16. Jäättelä M., Cande C., and Kroemer G. Lysosomes and mitochondria in the commitment to apoptosis: a potential role for cathepsin D and AIF. Cell Death Differ 11 (2004) 135-136
17. Kågedal K., Johansson U., and Ollinger K. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J 15 (2001) 1592-1594
18. Kikuchi H., Yamada T., Furuya H., Doh-ura K., Ohyagi Y., Iwaki T., and Kira J. Involvement of cathepsin B in the motor neuron degeneration of amyotrophic lateral sclerosis. Acta Neuropathol 105 (2003) 462-468
19. Koike M., Nakanishi H., Saftig P., Ezaki J., Isahara K., Ohsawa Y., Schulz-Schaeffer W., Watanabe T., Waguri S., Kametaka S., Shibata M., Yamamoto K., Kominami E., Peters C., von Figura K., and Uchiyama Y. Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J Neurosci 20 (2000) 6898-6906
20. Kos J., and Lah T.T. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer. Oncol Rep 5 (1998) 1349-1361
21. Li M., Ona V.O., Guegan C., Chen M., Jackson-Lewis V., Andrews L.J., Olszewski A.J., Stieg P.E., Lee J.P., Przedborski S., and Friedlander R.M. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288 (2000) 335-339
22. Liu J., Lillo C., Jonsson P.A., Vande Velde C., Ward C.M., Miller T.M., Subramaniam J.R., Rothstein J.D., Marklund S., Andersen P.M., Brannstrom T., Gredal O., Wong P.C., Williams D.S., and Cleveland D.W. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43 (2004) 5-17
23. Lorenzl S., Narr S., Angele B., Krell H.W., Gregorio J., Kiaei M., Pfister H.W., and Beal M.F. The matrix metalloproteinases inhibitor Ro 26-2853 extends survival in transgenic ALS mice. Exp Neurol 200 (2006) 166-171
24. Lu A., Tang Y., Ran R., Clark J.F., Aronow B.J., and Sharp F.R. Genomics of the periinfarction cortex after focal cerebral ischemia. J Cereb Blood Flow Metab 23 (2003) 786-810
25. Nagai A., Ryu J.K., Terashima M., Tanigawa Y., Wakabayashi K., McLarnon J.G., Kobayashi S., Masuda J., and Kim S.U. Neuronal cell death induced by cystatin C in vivo and in cultured human CNS neurons is inhibited with cathepsin B. Brain Res 1066 (2005) 120-128
26. Nylandsted J., Gyrd-Hansen M., Danielewich A., Fehrenbacher N., Lademann U., Hoyer-Hansen M., Weber E., Multhoff G., Rohde M., and Jäättelä M. HSP70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 200 (2004) 425-435
27. Okamoto K., Hirai S., Amari M., Watanabe M., and Sakurai A. Bunina bodies in amyotrophic lateral sclerosis immunostained with rabbit anti-cystatin C serum. Neurosci Lett 162 (1993) 125-128
28. Olsson T., Nygren J., Hakansson K., Lundblad C., Grubb A., Smith M.L., and Wieloch T. Gene deletion of cystatin C aggravates brain damage following focal ischemia but mitigates the neuronal injury after global ischemia in the mouse. Neuroscience 128 (2004) 65-71
29. Pasinelli P., Houseweart M.K., Brown Jr. R.H., and Cleveland D.W. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu, Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 97 (2000) 13901-13906
30. Pasinetti G.M., Ungar L.H., Lange D.J., Yemul S., Deng H., Yuan X., Brown R.H., Cudkowicz M.E., Newhall K., Peskind E., Marcus S., and Ho L. Identification of potential CSF biomarkers in ALS. Neurology 66 (2006) 1218-1222
31. Pennacchio L.A., Lehesjoki A.-E., Stone N.E., Willour V.L., Virtaneva K., Miao J., D'Amato E., Ramirez L., Faham M., Koskiniemi M., Warrington J., Norio R., de la Chapelle A., Cox D.R., and Myers R.M. Mutations in the gene encoding cystatin B cause progressive myoclonus epilepsy (EPM1). Science 271 (1996) 1731-1734
32. Pennacchio L.A., Bouley D.M., Higgins K.M., Scott M.P., Noebels J.L., and Myers R.M. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat Genet 20 (1998) 251-258
33. Pirttilä T.J., Lukasiuk K., Hakansson K., Grubb A., Abrahamson M., and Pitkanen A. Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse. Neurobiol Dis 20 (2005) 241-253
34. Ranganathan S., Williams E., Ganchev P., Gopalakrishnan V., Lacomis D., Urbinelli L., Newhall K., Cudkowicz M.E., Brown Jr. R.H., and Bowser R. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amytrophic lateral sclerosis. J Neurochem 95 (2005) 1461-1471
35. Riccio M., Santi S., Dembic M., Di Giaimo R., Cipollini E., Costantino-Ceccarini E., Ambrosetti D., Maraldi N.M., and Melli M. Cell-specific expression of the epm1 (cystatin B) gene in developing rat cerebellum. Neurobiol Dis 20 (2005) 104-114
36. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
37. Sastre M., Calero M., Pawlik M., Mathews P.M., Kumar A., Danilov V., Schmidt S.D., Nixon R.A., Frangione B., and Levy E. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation. Neurobiol Aging 25 (2004) 1033-1043
38. Trapp T., Korhonen L., Besselmann M., Martinez R., Mercer E.A., and Lindholm D. Transgenic mice overexpressing XIAP in neurons show better outcome after transient cerebral ischemia. Mol Cell Neurosci 23 (2003) 302-313
39. Turk V., Turk B., and Turk D. Lysosomal cysteine proteases: facts and opportunities. EMBO J 20 (2001) 4629-4633
40. Virtaneva K., D'Amato E., Miao J., Koskiniemi M., Norio R., Avanzini G., Franceschetti S., Michelucci R., Tassinari C.A., Omer S., Pennacchio L.A., Myers R.M., Dieguez-Lucena J.L., Krahe R., de la Chapelle A., and Lehesjoki A.-E. Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet 15 (1997) 393-396
41. van Welsem M.E., Hogenhuis J.A., Meininger V., Metsaars W.P., Hauw J.J., and Seilhean D. The relationship between Bunina bodies, skein-like inclusions and neuronal loss in amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 103 (2002) 583-589
42. Wang X., Zhu C., Wang X., Hagberg H., Korhonen L., Sandberg M., Lindholm D., and Blomgren K. X-linked inhibitor of apoptosis (XIAP) protein protects against caspase activation and tissue loss after neonatal hypoxia-ischemia. Neurobiol Dis 16 (2004) 179-189
43. Watanabe M., Jackson M., Ikeda M., Mizushima K., Amari M., Takatama M., Hirai S., Ikeda Y., Shizuka-Ikeda M., and Okamoto K. Genetic analysis of the cystatin C gene in familial and sporadic ALS patients. Brain Res 1073- 1074 (2006) 20-24
44. Wootz H., Hansson I., Korhonen L., Näpänkangas U., and Lindholm D. Caspase-12 cleavage and increased oxidative stress during motoneuron degeneration in transgenic mouse model of ALS. Biochem Biophys Res Commun 322 (2004) 281-286
45. Wootz H., Hansson I., Korhonen L., and Lindholm D. XIAP decreases caspase-12 cleavage and calpain activity in spinal cord of ALS transgenic mice. Exp Cell Res 312 (2006) 1890-1898
46. Yan S., and Sloane B.F. Molecular regulation of human cathepsin B: implication in pathologies. Biol Chem 384 (2003) 845-854